Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 35 studies | 36% ± 20% | |
| endothelial cell of lymphatic vessel | 18 studies | 39% ± 17% | |
| non-classical monocyte | 11 studies | 44% ± 28% | |
| classical monocyte | 10 studies | 35% ± 23% | |
| endothelial cell of vascular tree | 10 studies | 27% ± 5% | |
| capillary endothelial cell | 9 studies | 30% ± 12% | |
| endothelial cell of artery | 8 studies | 31% ± 9% | |
| vein endothelial cell | 8 studies | 30% ± 11% | |
| conventional dendritic cell | 6 studies | 41% ± 27% | |
| microglial cell | 6 studies | 28% ± 9% | |
| myeloid cell | 5 studies | 33% ± 15% | |
| hematopoietic precursor cell | 4 studies | 49% ± 31% | |
| glomerular endothelial cell | 4 studies | 39% ± 9% | |
| monocyte | 4 studies | 21% ± 9% | |
| ciliated cell | 4 studies | 24% ± 6% | |
| erythrocyte | 4 studies | 34% ± 14% | |
| basal cell | 3 studies | 24% ± 2% | |
| hematopoietic stem cell | 3 studies | 47% ± 27% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 55% ± 23% | |
| erythroblast | 3 studies | 62% ± 26% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 4 studies | 35% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1924.13 | 2632 / 2642 | 100% | 74.07 | 705 / 705 |
| thymus | 100% | 2144.96 | 652 / 653 | 99% | 30.20 | 600 / 605 |
| kidney | 100% | 2161.80 | 89 / 89 | 97% | 34.01 | 877 / 901 |
| breast | 100% | 2101.88 | 459 / 459 | 97% | 16.80 | 1083 / 1118 |
| adrenal gland | 99% | 963.29 | 256 / 258 | 97% | 25.97 | 224 / 230 |
| prostate | 100% | 1141.40 | 244 / 245 | 90% | 11.04 | 450 / 502 |
| uterus | 100% | 1383.60 | 170 / 170 | 89% | 17.28 | 407 / 459 |
| lung | 100% | 3007.79 | 578 / 578 | 86% | 12.94 | 999 / 1155 |
| bladder | 95% | 916.24 | 20 / 21 | 82% | 16.58 | 412 / 504 |
| esophagus | 98% | 932.26 | 1421 / 1445 | 77% | 8.96 | 140 / 183 |
| ovary | 76% | 558.12 | 136 / 180 | 85% | 11.41 | 364 / 430 |
| intestine | 94% | 831.20 | 908 / 966 | 61% | 7.59 | 319 / 527 |
| stomach | 80% | 526.06 | 288 / 359 | 71% | 8.91 | 203 / 286 |
| skin | 68% | 543.08 | 1224 / 1809 | 69% | 10.57 | 327 / 472 |
| pancreas | 38% | 179.81 | 126 / 328 | 96% | 20.20 | 170 / 178 |
| liver | 35% | 154.46 | 78 / 226 | 77% | 8.56 | 311 / 406 |
| adipose | 100% | 1843.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 149.13 | 29 / 29 |
| spleen | 100% | 2914.59 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1759.84 | 799 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1960.78 | 902 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 92% | 1081.10 | 1226 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 87% | 11.44 | 39 / 45 |
| heart | 83% | 466.50 | 711 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 21% | 1.68 | 17 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
| GO_0001221 | Molecular function | transcription coregulator binding |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0140297 | Molecular function | DNA-binding transcription factor binding |
| GO_0043425 | Molecular function | bHLH transcription factor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | LMO2 |
| Protein name | Rhombotin-2 (Cysteine-rich protein TTG-2) (LIM domain only protein 2) (LMO-2) (T-cell translocation protein 2) |
| Synonyms | TTG2 RBTNL1 RHOM2 RBTN2 |
| Description | FUNCTION: Acts with TAL1/SCL to regulate red blood cell development. Also acts with LDB1 to maintain erythroid precursors in an immature state. |
| Accessions | P25791 ENST00000411482.1 [P25791-4] ENST00000257818.3 [P25791-3] ENST00000395833.7 [P25791-1] |